We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+2.29%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.85B
AUM Growth
-$497M
Cap. Flow
-$376M
Cap. Flow %
-13.23%
Top 10 Hldgs %
22.47%
Holding
2,268
New
669
Increased
298
Reduced
432
Closed
770

Top Buys

Rank Stock Value
1
DRE
Duke Realty Corp.
DRE
+$174M
2
CTXS
Citrix Systems Inc
CTXS
+$134M
3
INVH icon
Invitation Homes
INVH
+$46.4M
4
MS icon
Morgan Stanley
MS
+$44.3M
5
SNPS icon
Synopsys
SNPS
+$43.7M

Top Sells

Rank Stock Value
1
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$79.9M
2
NXPI icon
NXP Semiconductors
NXPI
+$52.5M
3
OXY icon
Occidental Petroleum
OXY
+$45M
4
YUMC icon
Yum China
YUMC
+$40.8M
5
IBB icon
iShares Biotechnology ETF
IBB
+$39M

Sector Composition

Rank Sector Weight
1 Technology 20.43%
2 Financials 14.47%
3 Healthcare 11.04%
4 Real Estate 11%
5 Industrials 9.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LSF icon
1451
Laird Superfood
LSF
$46.2M
$44K ﹤0.01%
23,984
-6,616
-22% -$14.6K
ATNX
1452
DELISTED
Athenex, Inc. Common Stock
ATNX
$43K ﹤0.01%
8,029
-13,076
-62% -$134K
CRGE
1453
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$42K ﹤0.01%
+23,636
New +$67.4K
RMO
1454
DELISTED
Romeo Power, Inc.
RMO
$42K ﹤0.01%
103,754
-406,346
-80% -$245K
UPH
1455
DELISTED
UpHealth, Inc.
UPH
$40K ﹤0.01%
+7,445
New +$44.5K
XLO icon
1456
Xilio Therapeutics
XLO
$56.9M
$38K ﹤0.01%
924
-329
-26% -$12.8K
QTNT
1457
DELISTED
Quotient Limited Ordinary Shares
QTNT
$38K ﹤0.01%
6,399
-3,384
-35% -$30.5K
HOFV
1458
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$37K ﹤0.01%
3,060
-6,054
-66% -$105K
OPAD icon
1459
Offerpad Solutions
OPAD
$19M
$37K ﹤0.01%
+201
New +$54.2K
TLIS
1460
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$37K ﹤0.01%
3,586
-1,042
-23% -$13.2K
AMRX icon
1461
Amneal Pharmaceuticals
AMRX
$5.72B
$36K ﹤0.01%
+17,759
New +$49.8K
SPRB
1462
Spruce Biosciences
SPRB
$119M
$32K ﹤0.01%
307
-252
-45% -$35.2K
GATO
1463
DELISTED
Gatos Silver, Inc.
GATO
$32K ﹤0.01%
11,944
-194,856
-94% -$610K
SGTX
1464
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$32K ﹤0.01%
4,860
-644
-12% -$5.88K
BINI
1465
DELISTED
Bollinger Innovations
BINI
– –
0
– –
CDAK
1466
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$30K ﹤0.01%
38,019
-34,960
-48% -$73.4K
LOTZ
1467
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$27K ﹤0.01%
90,603
-248,022
-73% -$108K
ISO
1468
DELISTED
IsoPlexis Corporation Common Stock
ISO
$26K ﹤0.01%
14,980
-4,140
-22% -$10.2K
RVLP
1469
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$23K ﹤0.01%
+10,927
New +$21.2K
ADV icon
1470
Advantage Solutions
ADV
$484M
$22K ﹤0.01%
420
-2,856
-87% -$263K
WULF icon
1471
TeraWulf
WULF
$9.15B
$20K ﹤0.01%
+16,031
New +$22.3K
FBRX icon
1472
Forte Biosciences
FBRX
$1.12B
$19K ﹤0.01%
728
-1,288
-64% -$40.9K
TISI icon
1473
Team
TISI
$77.7M
$19K ﹤0.01%
1,831
-7,808
-81% -$83.6K
GHSI
1474
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$19K ﹤0.01%
+2,754
New +$21K
NH
1475
DELISTED
NantHealth, Inc
NH
$19K ﹤0.01%
5,008
-761
-13% -$5.41K
57 58
59
60 61

Similar funds

ROC
River Oaks Capital Wayzata, Minnesota $67.9M AUM 13.58% 1-Year Est. Return
IVMX
Institutional Venture Management XIV Menlo Park, California $67.7M AUM 8.12% 1-Year Est. Return
AM
Anqa Management Sag Harbor, New York $66.5M AUM 36.45% 1-Year Est. Return
JCG
John C. Goff $70.7M AUM 4.99% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
FA
Financial Advantage Columbia, Maryland $65.2M AUM 14.55% 1-Year Est. Return
VCM
Vetamer Capital Management Menlo Park, California $72M AUM 31% 1-Year Est. Return
MCMI
Matrix China Management IV Grand Cayman, Cayman Islands $64.3M AUM 53.64% 1-Year Est. Return

Ergoteles's Q3 2022 Portfolio in Review

As of Q3 2022, Ergoteles held 2,268 positions worth $2.85B, down 15% from $3.34B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Ergoteles withdrew a net $376M in Q3 2022, closing 770 positions and reducing 432 holdings. Its most notable exit was Yum China, an estimated $40.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ergoteles opened a new position in Morgan Stanley worth $41.5M.

  • Ergoteles's largest Q3 2022 buy was Morgan Stanley: 525,381 shares worth $41.5M.
  • Ergoteles added most to Duke Realty Corp. in Q3 2022, an estimated $174M increase.
  • Ergoteles's biggest Q3 2022 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $79.9M.
  • Ergoteles fully exited Yum China in Q3 2022, selling an estimated $40.8M.
  • Ergoteles's ten largest holdings make up 22% of its $2.85B portfolio in Q3 2022.
  • Ergoteles opened 669 new positions and closed 770 in Q3 2022.
  • Ergoteles's portfolio value fell 15% quarter-over-quarter to $2.85B.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.